
Raw ESG Data | Controversy Screening for 10K+ companies
# | Entity ID |
Company Name |
Entity Type |
ISIN |
Inrate Sector |
Inrate Sub-Sector |
Entity CS Score |
Last Date of Treatment |
controversies over access to basic needs |
controversies over access to economic opportunity |
controversies over activities in sensitive countries |
controversies over anti-competitive practices |
controversies over bribery and corruption |
controversies over charitable donations |
controversies over child / forced labour |
controversies over content and privacy of data |
controversies over discrimination and (sexual) abuse |
controversies over employment conditions |
controversies over environmental pollution |
controversies over ethical issues over research activities |
controversies over financing, investing in or insuring activities harmful to biodiversity |
controversies over financing, investing in or insuring of high ghg activities |
controversies over freedom of association |
controversies over ghg impact |
controversies over gmo labelling practices |
controversies over governance practices |
controversies over health and safety |
controversies over health impact of products and services |
controversies over involvement in controversial projects |
controversies over land- and sea-use change |
controversies over lending practices |
controversies over lobbying activities (incl. political donations) and positions |
controversies over local communities |
controversies over marketing and advertising practices |
controversies over money laundering |
controversies over other business ethics issues |
controversies over other social impact of products and services (not on health) |
controversies over over-exploitation of natural resources |
controversies over remuneration |
controversies over restructuring |
controversies over shareholders rights |
controversies over tax issues |
controversies over employment conditions among employees |
Sector |
Industry Group |
Industry |
Sub-Industry |
Region |
Country type |
Country |
RIC |
Rating ID |
Rating Cycle Release Date |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | xxxxxxxxxx | Xxxxxxxxx | xxxxxx | xxxxxxxxxx | Xxxxx | Xxxxxx | Xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | Xxxxxxxxxx | xxxxxxxxx | Xxxxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxxx | Xxxxx | xxxxxxxxxx | xxxxxx | Xxxxxxxxxx | xxxxxx | Xxxxx | Xxxxxx | xxxxx | xxxxxxxx | xxxxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxxx | xxxxxx | Xxxxxxxxx | xxxxxx | Xxxxxxxxx | Xxxxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxx | xxxxxx | xxxxxxx | xxxxxxx | Xxxxx | xxxxxx | Xxxxxxxxxx | xxxxxxxx | xxxxxx | Xxxxx | Xxxxxxx | xxxxxx | Xxxxxxxx | Xxxxxxx | Xxxxx | xxxxxx | xxxxxxxxxx | Xxxxx |
2 | xxxxxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxxxxx | xxxxxxxx | Xxxxxxxxxx | Xxxxxxxx | Xxxxxxxx | xxxxxxxxx | Xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | xxxxx | xxxxxxx | xxxxxxxxx | Xxxxxx | Xxxxxxx | Xxxxxxxxx | xxxxxxxxx | xxxxxxxxx | Xxxxx | xxxxxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxx | Xxxxxxx | xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxxx | xxxxxx | Xxxxxxxxx | xxxxx | Xxxxxxxxxx | xxxxxx | xxxxx | xxxxxxxx | Xxxxxx | Xxxxxxxxxx | xxxxxxxxx | Xxxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxx | xxxxx | xxxxxxxx |
3 | xxxxxx | Xxxxxxxxxx | xxxxxxxxxx | Xxxxx | xxxxxxx | Xxxxxxxx | Xxxxxxx | xxxxx | xxxxxxxx | xxxxxxxxxx | Xxxxxx | xxxxxxxxx | Xxxxx | xxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxx | xxxxxxxxx | xxxxxxx | Xxxxxx | xxxxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxxxx | xxxxxxxx | Xxxxxxxx | Xxxxxxxx | xxxxxxxx | xxxxxxxxx | Xxxxxxx | Xxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxxxxxx | xxxxxxxxxx | xxxxxx | Xxxxx | Xxxxxxx | Xxxxx | Xxxxxx | Xxxxx | Xxxxxxxxx | xxxxxx | xxxxxxxx | Xxxxxxxxx | Xxxxxx | Xxxxxxxxxx | Xxxxxx | Xxxxx |
4 | Xxxxxxx | xxxxxxxxx | Xxxxx | xxxxx | Xxxxxx | xxxxxxxxx | xxxxxxx | xxxxxxxxx | Xxxxxxxxxx | xxxxxxxxx | Xxxxx | Xxxxx | Xxxxxxxxx | xxxxxxxxxx | xxxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxx | Xxxxxxxxxx | Xxxxxxxxxx | Xxxxxxxx | Xxxxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxxxxx | Xxxxxxxx | xxxxxxxxxx | xxxxxxx | Xxxxxxxx | xxxxx | Xxxxxx | xxxxxx | xxxxxxxx | xxxxxxx | Xxxxx | Xxxxxxxxx | Xxxxx | Xxxxxxx | Xxxxxxxx | xxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxxxxxx | Xxxxxxx | xxxxxxxxx | xxxxxxx | xxxxxxxxxx | xxxxxx | xxxxx | Xxxxxxxxxx | Xxxxxxxxx | xxxxxxx |
5 | Xxxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxx | xxxxxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxx | Xxxxx | xxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | xxxxxxx | Xxxxxxxx | xxxxx | xxxxx | Xxxxxxxxxx | Xxxxxxx | Xxxxxxxx | Xxxxxxx | xxxxx | xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxxxxxxx | xxxxxxx | Xxxxx | xxxxxxxxx | xxxxxxxx | Xxxxxxxx | xxxxxxxx | Xxxxxxx | Xxxxxx | Xxxxxxxxx | Xxxxxxxx | Xxxxxxxxxx | Xxxxxxx | Xxxxxx | Xxxxxxxxxx | xxxxxxxxxx | xxxxxxxxxx | Xxxxxxx | Xxxxx | Xxxxx | Xxxxx | Xxxxxxx | xxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxx | xxxxxx |
6 | xxxxxxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxx | Xxxxx | xxxxxxx | Xxxxxx | Xxxxx | xxxxxxxxxx | xxxxxxxxx | Xxxxxxxxxx | Xxxxxxxxx | Xxxxxxxx | xxxxxxxxx | Xxxxxxx | Xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxxxxxx | Xxxxxxx | Xxxxxxx | xxxxxxxx | xxxxx | Xxxxx | Xxxxxxxx | xxxxxxxx | Xxxxxxxxx | xxxxxxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxxxxxx | Xxxxxxx | Xxxxxxx | Xxxxxxx | Xxxxxxx | xxxxxxx | Xxxxxxxxxx | xxxxxxxx | Xxxxx | xxxxxxxxxx | xxxxxxxxxx | xxxxxx | xxxxxxxx | Xxxxxxxx | xxxxxx | xxxxxxxx | xxxxxx | Xxxxxxxx | xxxxxxxxx | xxxxx | Xxxxxxxxxx | Xxxxxxxxx | Xxxxxxx |
7 | xxxxxxxx | Xxxxxxx | Xxxxxxxxxx | Xxxxxxxxx | xxxxxxxxxx | xxxxxxx | Xxxxxxxxx | xxxxxxxxx | xxxxxxxx | xxxxxxxxx | xxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | Xxxxxxxxxx | xxxxxxx | Xxxxxxxxxx | Xxxxxxxxx | Xxxxxx | xxxxxxxx | xxxxxxxxxx | xxxxxxxx | Xxxxx | xxxxxxxx | xxxxxxxxxx | xxxxxxxx | Xxxxx | xxxxxxxx | xxxxxx | Xxxxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxxx | Xxxxxxxxx | xxxxxx | Xxxxx | Xxxxx | Xxxxxx | Xxxxxxxxx | Xxxxxxxxx | xxxxx | Xxxxx | Xxxxxxxxxx | Xxxxxxx | Xxxxxxxxxx | Xxxxxxxx | xxxxxxx | xxxxxxxx | Xxxxxx | Xxxxxxxxx |
8 | Xxxxxxxxxx | Xxxxxx | Xxxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxxx | Xxxxxxxxxx | xxxxx | xxxxxxx | xxxxxxxxx | xxxxxxxxx | xxxxxx | xxxxxx | Xxxxxxxxxx | xxxxxxxxxx | xxxxxxxxx | Xxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxxx | Xxxxxxxx | Xxxxxxx | xxxxxx | xxxxx | xxxxx | Xxxxxxxxx | xxxxx | Xxxxx | Xxxxxx | xxxxxxxxxx | Xxxxxxxx | Xxxxxxxx | Xxxxxxxxx | Xxxxxxxxxx | xxxxxx | Xxxxx | Xxxxxxxx | xxxxxx | Xxxxx | Xxxxxx | xxxxxx | xxxxxxxx | Xxxxxxxx | Xxxxxxxxxx | xxxxxxxxxx | Xxxxx | Xxxxxxx | Xxxxxxx | Xxxxxx | Xxxxxx | xxxxxxxx |
9 | Xxxxxxxxx | Xxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxxxxx | xxxxxxx | Xxxxxxxx | Xxxxxxxxxx | xxxxxx | xxxxxxxxxx | xxxxxx | xxxxxx | Xxxxxxxxxx | xxxxxxx | Xxxxxxxxxx | xxxxx | Xxxxxxxxx | Xxxxxxx | Xxxxxxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxx | xxxxxxxxxx | xxxxx | xxxxxxxxxx | xxxxxxx | xxxxxxxx | Xxxxx | xxxxx | xxxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxxxx | Xxxxxxxxx | xxxxxxx | Xxxxxxx | Xxxxxxxxxx | Xxxxxxxx | xxxxxx | xxxxxx | Xxxxxx | xxxxxx | xxxxx | Xxxxxxxxx | Xxxxxxxxx | Xxxxxx | Xxxxx | Xxxxxxxxx | Xxxxxx | Xxxxxx | xxxxxx | xxxxx | xxxxxxx |
10 | xxxxxxxxxx | xxxxxx | Xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxx | xxxxxxx | xxxxxxx | Xxxxxxxxxx | Xxxxx | xxxxxxx | Xxxxxxxx | Xxxxxx | xxxxxxxxxx | Xxxxx | Xxxxxxx | xxxxx | xxxxxx | xxxxxx | Xxxxxxxx | xxxxxxx | Xxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxx | xxxxxxxxxx | Xxxxx | Xxxxxx | Xxxxxx | xxxxxx | Xxxxxxxx | Xxxxx | xxxxx | Xxxxxxxxxx | xxxxxx | xxxxx | xxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxxx | xxxxxxxxxx | xxxxxxx | xxxxxxx | xxxxxxxxxx | Xxxxxxxxxx | Xxxxxx | xxxxxx | Xxxxxxxxxx |
... | Xxxxxx | Xxxxxx | Xxxxxxx | Xxxxxx | xxxxxxxx | xxxxx | Xxxxxxxxxx | Xxxxx | xxxxxxx | xxxxxxxx | xxxxxxxx | Xxxxxxxx | xxxxxxx | xxxxxx | Xxxxxxxx | xxxxxxx | Xxxxxxxxxx | xxxxxxxx | xxxxxxxx | xxxxxx | Xxxxxxxx | xxxxx | Xxxxx | Xxxxxxxxx | xxxxxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxxx | Xxxxx | Xxxxxxxx | Xxxxxxxxx | xxxxxxxxxx | Xxxxxx | xxxxxxxxx | Xxxxxx | Xxxxxxxxxx | Xxxxxx | xxxxxxxx | xxxxxx | xxxxxxxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxxx | Xxxxxxxxxx | xxxxxxxxxx | Xxxxxxxxx | xxxxxxxx | xxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxx |
# | Entity ID |
Parent ID |
Company Name |
Entity Type |
Inrate Sector |
Entity CS Score |
Controversy Category |
Controversy Indicator |
CS Indicator Score |
Event Title |
Keypoint Summary |
Source |
Date of Treatment |
Time Discount |
CS Event Score after time discount (numeric) |
CS Event Score after time discount |
Region |
Country Type |
Country Code |
Country |
Rating ID |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | xxxxxxxxxx | Xxxxxxxxx | xxxxxx | xxxxxxxxxx | Xxxxx | Xxxxxx | Xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | Xxxxxxxxxx | xxxxxxxxx | Xxxxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxxx | Xxxxx | xxxxxxxxxx | xxxxxx | Xxxxxxxxxx | xxxxxx | Xxxxx |
2 | Xxxxxx | xxxxx | xxxxxxxx | xxxxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxxx | xxxxxx | Xxxxxxxxx | xxxxxx | Xxxxxxxxx | Xxxxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxx | xxxxxx | xxxxxxx | xxxxxxx | Xxxxx | xxxxxx | Xxxxxxxxxx |
3 | xxxxxxxx | xxxxxx | Xxxxx | Xxxxxxx | xxxxxx | Xxxxxxxx | Xxxxxxx | Xxxxx | xxxxxx | xxxxxxxxxx | Xxxxx | xxxxxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxxxxx | xxxxxxxx | Xxxxxxxxxx | Xxxxxxxx | Xxxxxxxx | xxxxxxxxx | Xxxxxxxxxx |
4 | Xxxxxx | Xxxxxxxxx | xxxxx | xxxxxxx | xxxxxxxxx | Xxxxxx | Xxxxxxx | Xxxxxxxxx | xxxxxxxxx | xxxxxxxxx | Xxxxx | xxxxxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxxx | xxxxx | Xxxxxxx | xxxxxxx | Xxxxx | xxxxxxxxxx | Xxxxxxx |
5 | Xxxxx | xxxxxxxxxx | Xxxxxx | xxxxxx | Xxxxxxxxx | xxxxx | Xxxxxxxxxx | xxxxxx | xxxxx | xxxxxxxx | Xxxxxx | Xxxxxxxxxx | xxxxxxxxx | Xxxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxx | xxxxx |
6 | xxxxxxxx | xxxxxx | Xxxxxxxxxx | xxxxxxxxxx | Xxxxx | xxxxxxx | Xxxxxxxx | Xxxxxxx | xxxxx | xxxxxxxx | xxxxxxxxxx | Xxxxxx | xxxxxxxxx | Xxxxx | xxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxx |
7 | xxxxxxxxx | xxxxxxx | Xxxxxx | xxxxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxx | Xxxxxxxx | xxxxxxxx | Xxxxxxxx | Xxxxxxxx | xxxxxxxx | xxxxxxxxx | Xxxxxxx | Xxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxxxxxx | xxxxxxxxxx | xxxxxx | Xxxxx |
8 | Xxxxxxx | Xxxxx | Xxxxxx | Xxxxx | Xxxxxxxxx | xxxxxx | xxxxxxxx | Xxxxxxxxx | Xxxxxx | Xxxxxxxxxx | Xxxxxx | Xxxxx | Xxxxxxx | xxxxxxxxx | Xxxxx | xxxxx | Xxxxxx | xxxxxxxxx | xxxxxxx | xxxxxxxxx | Xxxxxxxxxx |
9 | xxxxxxxxx | Xxxxx | Xxxxx | Xxxxxxxxx | xxxxxxxxxx | xxxxxx | xxxxxxxxx | xxxxxxx | Xxxxxxx | Xxxxxxxxxx | Xxxxxxxxxx | Xxxxxxxx | Xxxxxxxxx | xxxxx | Xxxxxxx | xxxxxxxxxx | Xxxxxxxxx | Xxxxxxxx | xxxxxxxxxx | xxxxxxx | Xxxxxxxx |
10 | xxxxx | Xxxxxx | xxxxxx | xxxxxxxx | xxxxxxx | Xxxxx | Xxxxxxxxx | Xxxxx | Xxxxxxx | Xxxxxxxx | xxxxxxxxx | xxxxxxxx | xxxxx | Xxxxxxxxxx | Xxxxxxx | xxxxxxxxx | xxxxxxx | xxxxxxxxxx | xxxxxx | xxxxx | Xxxxxxxxxx |
... | Xxxxxxxxx | xxxxxxx | Xxxxxx | Xxxxx | Xxxxxxxx | xxxxxxxxx | xxxxxxxx | Xxxxxx | xxxxxxxxxx | xxxxxxxxx | xxxxx | Xxxxx | xxxxxxx | xxxxxxxxxx | Xxxxxx | Xxxxxxxxx | xxxxxxx | Xxxxxxxx | xxxxx | xxxxx | Xxxxxxxxxx |
Data Dictionary
Attribute | Type | Example | Mapping |
---|---|---|---|
Entity ID
|
Integer | 437 | |
Company Name
|
String | Assa Abloy | |
Entity Type
|
String | Equity | |
ISIN
|
String | SE0007100581 | |
Inrate Sector
|
String | Housing | |
Inrate Sub-Sector
|
String | Building products | |
Entity CS Score
|
Float | 0.000128625 | |
Last Date of Treatment
|
String | 9/11/2023 | |
controversies over access to basic needs
|
Float | 0.081 | |
controversies over access to economic opportunity
|
Float | 0.001 | |
controversies over activities in sensitive countries
|
Float | 0.081 | |
controversies over anti-competitive practices
|
Float | 0.000128625 | |
controversies over bribery and corruption
|
Float | 0.081 | |
controversies over charitable donations
|
Float | 0 | |
controversies over child / forced labour
|
Float | 0.00625 | |
controversies over content and privacy of data
|
Float | 0.001 | |
controversies over discrimination and (sexual) abuse
|
Float | 0.081 | |
controversies over employment conditions
|
Float | 0 | |
controversies over environmental pollution
|
Float | 0.077 | |
controversies over ethical issues over research activities
|
Float | 0.000128625 | |
controversies over financing, investing in or insuring activities harmful to biodiversity
|
Float | 0.081 | |
controversies over financing, investing in or insuring of high ghg activities
|
Float | 0 | |
controversies over freedom of association
|
Float | 0.000128625 | |
controversies over ghg impact
|
Float | 0.001 | |
controversies over gmo labelling practices
|
Float | 0.077 | |
controversies over governance practices
|
Float | 0.0072551 | |
controversies over health and safety
|
Float | 0.00132 | |
controversies over health impact of products and services
|
Float | 0 | |
controversies over involvement in controversial projects
|
Float | 0.0063 | |
controversies over land- and sea-use change
|
Float | 0.00672 | |
controversies over lending practices
|
Float | 0.000128625 | |
controversies over lobbying activities (incl. political donations) and positions
|
Float | 0.00243 | |
controversies over local communities
|
Float | 0.001 | |
controversies over marketing and advertising practices
|
Float | 0.000128625 | |
controversies over money laundering
|
Float | 0 | |
controversies over other business ethics issues
|
Float | 0.000128625 | |
controversies over other social impact of products and services (not on health)
|
Float | 0.077 | |
controversies over over-exploitation of natural resources
|
Float | 0.001 | |
controversies over remuneration
|
Float | 0.076242 | |
controversies over restructuring
|
Float | 0.000128625 | |
controversies over shareholders rights
|
Float | 0.077 | |
controversies over tax issues
|
Float | 0.000128625 | |
controversies over employment conditions among employees
|
Float | 0.001 | |
Sector
|
String | Industrials | |
Industry Group
|
String | Capital Goods | |
Industry
|
String | Building Products | |
Sub-Industry
|
String | Building Products | |
Region
|
String | Europe | |
Country type
|
String | Developed Markets | |
Country
|
String | Sweden | |
RIC
|
String | ASSAb.ST | |
Rating ID
|
Integer | 437 | |
Rating Cycle Release Date
|
String | 9/11/2024 |
Attribute | Type | Example | Mapping |
---|---|---|---|
Entity ID
|
Integer | 100874 | |
Parent ID
|
|||
Company Name
|
String | 360 Security Technology Inc | |
Entity Type
|
String | Equity | |
Inrate Sector
|
String | Software | |
Entity CS Score
|
String | Low | |
Controversy Category
|
String | Impact on local communities | |
Controversy Indicator
|
String | activities in sensitive countries | |
CS Indicator Score
|
String | Considerable | |
Event Title
|
String | Contribution to human rights violations against the Uighu... | |
Keypoint Summary
|
String | In December 2017, 360 Security Technology Inc. stated tha... | |
Source
|
String | https://sourcingjournal.com/topics/labor/skechers-donggua... | |
Date of Treatment
|
String | 5/31/2020 | |
Time Discount
|
Float | 0.8 | |
CS Event Score after time discount (numeric)
|
Float | 0.0356 | |
CS Event Score after time discount
|
String | Considerable | |
Region
|
String | Asia-Pacific | |
Country Type
|
String | EM | |
Country Code
|
String | CN | |
Country
|
String | China | |
Rating ID
|
Integer | 100874 |
Description
Country Coverage
History
Pricing
License | Starts at |
---|---|
One-off purchase | Available |
Monthly License | Not available |
Yearly License | Available |
Usage-based | Not available |
Suitable Company Sizes
Delivery
Use Cases
Categories
Related Searches
Related Products
Frequently asked questions
What is Raw ESG Data Controversy Screening for 10K+ companies?
Leverage Inrate’s advanced ESG Controversy assessments, powered by a proprietary news tool analyzing 200K+ sources and identifying 650 controversies daily. Our real-time ESG data is categorized into 34 indicators for simplified investment decisions, helping you assess material ESG risks efficiently.
What is Raw ESG Data Controversy Screening for 10K+ companies used for?
This product has 4 key use cases. Inrate recommends using the data for ESG Investing, Portfolio Construction, Portfolio Analysis, and ESG Performance Analysis. Global businesses and organizations buy ESG Data from Inrate to fuel their analytics and enrichment.
Who can use Raw ESG Data Controversy Screening for 10K+ companies?
This product is best suited if you’re a Small Business, Medium-sized Business, or Enterprise looking for ESG Data. Get in touch with Inrate to see what their data can do for your business and find out which integrations they provide.
How far back does the data in Raw ESG Data Controversy Screening for 10K+ companies go?
This product has 3 years of historical coverage. It can be delivered on a daily, weekly, monthly, quarterly, yearly, real-time, and on-demand basis.
Which countries does Raw ESG Data Controversy Screening for 10K+ companies cover?
This product includes data covering 140 countries like USA, China, Japan, Germany, and India. Inrate is headquartered in Switzerland.
How much does Raw ESG Data Controversy Screening for 10K+ companies cost?
Pricing information for Raw ESG Data Controversy Screening for 10K+ companies is available by getting in contact with Inrate. Connect with Inrate to get a quote and arrange custom pricing models based on your data requirements.
How can I get Raw ESG Data Controversy Screening for 10K+ companies?
Businesses can buy ESG Data from Inrate and get the data via SFTP, Email, UI Export, and REST API. Depending on your data requirements and subscription budget, Inrate can deliver this product in .csv and .xls format.
What is the data quality of Raw ESG Data Controversy Screening for 10K+ companies?
You can compare and assess the data quality of Inrate using Datarade’s data marketplace.
What are similar products to Raw ESG Data Controversy Screening for 10K+ companies?
This product has 3 related products. These alternatives include ESG Data Raw ESG Data Screening for 10K+ companies, Biodiversity Proximity Risk Data Climate Risk Data 14k+ companies IBAT Partnership, and TagX ESG Data ESG reports and Certifications Certifications data from more than 100 accredited agencies Certificate holders data. You can compare the best ESG Data providers and products via Datarade’s data marketplace and get the right data for your use case.